Panel Discussion: Balancing Speed, Safety, and Scale in hPSC-Derived Therapy Development

Learn from experts in hPSC biology, synthetic biology, bioprocess engineering, platform development, and regulatory strategy as they discuss challenges and opportunities for the development of hPSC-derived therapies.

Publish Date: March 05, 2026

See other videos & webinars

Webinar: Panel Discussion: Balancing Speed, Safety, and Scale in hPSC-Derived Therapy Development

To view the webinar, please complete the form, or sign in to your account.

I agree to receive future electronic communications from ��ƽ��. I acknowledge that I can unsubscribe at any time.

By submitting this form, you are providing your consent to ��ƽ�� Technologies Canada Inc. and its subsidiaries and affiliates (“��ƽ��”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.

Request Pricing

Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):

Estimated delivery time for your area

Product sample or exclusive offer

In-lab demonstration

Explore Our Products

�ձ𳧸�™-�� 3D

Animal origin-free suspension culture medium for human ES and iPS cells
�ձ𳧸�™-��

cGMP, animal origin-free, stabilized, feeder-free maintenance medium for human ES and iPS cells
CryoStor® CS10

Animal component-free, defined cryopreservation medium with 10% DMSO
PBS-MINI MagDrive Bioreactor

Compact bioreactor with single-use vessels for high-throughput, 3D suspension culture of hPSCs and other cell types

�����ƽ��